No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactinQIUSHUI HE; VILJANEN, Matti K; HINKKANEN, Ari E et al.Vaccine. 2005, Vol 23, Num 25, pp 3336-3340, issn 0264-410X, 5 p.Article

Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-γ) responses in atopic eczema dermatitis syndrome. evidence of CD4/CD8 and CD3/CD16⁺CD56 ratio elevations in vitroKOSONEN, Jan; LUHTALA, Marko; VIANDER, Markku et al.Experimental dermatology. 2005, Vol 14, Num 7, pp 551-558, issn 0906-6705, 8 p.Article

Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history studySIMELL, Satu; HOPPU, Sanna; KNIP, Mikael et al.The American journal of gastroenterology. 2007, Vol 102, Num 9, pp 2026-2035, issn 0002-9270, 10 p.Article

Gene Polymorphism in Toll-like Receptor 4: Effect on Antibody Production and Persistence After Acellular Pertussis Vaccination During AdolescenceGRÖNDAHL-YLI-HANNUKSELA, Kirsi; VUONONVIRTA, Juho; BARKOFF, Alex-Mikael et al.The Journal of infectious diseases. 2012, Vol 205, Num 8, pp 1214-1219, issn 0022-1899, 6 p.Article

Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. CommentaryLUNDIN, Knut E. A; SIMELL, Satu; ILONEN, Jorma et al.Scandinavian journal of gastroenterology. 2005, Vol 40, Num 10, pp 1137-1139, issn 0036-5521, 13 p.Article

Use of a genetic isolate to identify rare disease variants : C7 on 5p associated with MSKALLIO, Suvi P; JAKKULA, Eveliina; VIANDER, Markku et al.Human molecular genetics (Print). 2009, Vol 18, Num 9, pp 1670-1683, issn 0964-6906, 14 p.Article

Local challenge on oral mucosa with an α-gliadin related synthetic peptide in patients with celiac diseaseLÄHTEENOJA, Hannu; MÄKI, Markku; VIANDER, Markku et al.The American journal of gastroenterology. 2000, Vol 95, Num 10, pp 2880-2887, issn 0002-9270Article